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Arthrogryposis multiplex congenita (AMC) is caused by heterogeneous pathologies leading to multiple antenatal joint contractures
through fetal akinesia. Understanding the pathophysiology of this disorder is important for clinical care of the affected individuals
and genetic counseling of the families. We thus aimed to establish the genetic basis of an AMC subtype that is associated with multiple
dysmorphic features and intellectual disability (ID). We used haplotype analysis, next-generation sequencing, array comparative
genomic hybridization, and chromosome breakpoint mapping to identify the pathogenic mutations in families and simplex cases.
Suspected disease variants were verified by cosegregation analysis. We identified disease-causing mutations in the zinc-finger gene
ZC4H2 in four families affected by X-linked AMC plus ID and one family affected by cerebral palsy. Several heterozygous females
were also affected, but to a lesser degree. Furthermore, we found two ZC4H2 deletions and one rearrangement in two female and one
male unrelated simplex cases, respectively. In mouse primary hippocampal neurons, transiently produced ZC4H2 localized to the
postsynaptic compartment of excitatory synapses, and the altered protein influenced dendritic spine density. In zebrafish, antisense-
morpholino-mediated zc4h2 knockdown caused abnormal swimming and impaired a-motoneuron development. All missense
mutations identified herein failed to rescue the swimming defect of zebrafish morphants. We conclude that ZC4H2 point mutations,
rearrangements, and small deletions cause a clinically variable broad-spectrum neurodevelopmental disorder of the central and periph-
eral nervous systems in both familial and simplex cases of both sexes. Our results highlight the importance of ZC4H2 for genetic testing
of individuals presenting with ID plus muscle weakness and minor or major forms of AMC.Introduction
Arthrogryposis multiplex congenita (AMC) is a heteroge-
neous group of disorders with an incidence of 1 in
12,000 live births, symmetrical gender distribution, and
a perinatal mortality of 32%.1 It is characterized by
congenital joint contractures and is often associated with1Center for Frontier Research, National Institute of Genetics, Precursory Resea
Agency, Mishima 411-8540, Japan; 2Institute of Human Genetics, University o
pediatrics and NeuroCure Clinical Research Center, Charite´ Universita¨tsmedi
Adelaide, Adelaide, SA 5000, Australia; 5Department of Human Molecular Gen
6Universite´ Franc¸ois-Rabelais, 37032 Tours, France; 7Institut National de la San
Human Genetics, Westfa¨lischeWilhelms Universita¨t Mu¨nster, 48149Mu¨nster,
Hospital at Westmead, Sydney, NSW 2145, Australia; 10South Australian Clinic
Paediatrics and Reproductive Health, The University of Adelaide, Adelaide, SA
Berlin, 13353 Berlin, Germany; 13Neurogenetics, SA Pathology, Adelaide, SA 5
National de la Sante´ et de la RechercheMe´dicale Unite´ 1016, Centre National d
75014 Paris, France; 16Department of Computational Biology, Max Planck In
Mo¨nchberg, Kinderfachabteilung der Missionsa¨rztlichen Klinik Wu¨rzburg, 97
Hospital, Assistance Publique – Hoˆpitaux de Paris, 75014 Paris, France; 19Sign
20Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90
Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, U
St. Vincent Children’s Hospital, Indianapolis, IN 46260, USA; 23Departme
AZ Amsterdam, the Netherlands; 24Department of Medical Genetics, Centre H
25These authors contributed equally to this work
26Current address: Paw Print Genetics, Genetic Veterinary Sciences, Inc., Spok
*Correspondence: kalscheu@molgen.mpg.de (V.M.K.); for clinical information
http://dx.doi.org/10.1016/j.ajhg.2013.03.021. 2013 by The American Societ
The Amdecreased fetal movements, so-called fetal akinesia.2–4
AMC is seen in a variety of developmental defects of
the musculoskeletal and nervous systems, in connective-
tissue disorders, and in chromosomopathies.1 In AMC-
affected children, who show abnormal results on neuro-
logical examination, fetal akinesia might result from
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nervous system, the muscle, or the neuromuscular end-
plate.5 These conditions comprise antenatal spinal
muscular atrophy,4 hypomyelinating peripheral neuropa-
thies,6 connatal myasthenia caused by either transpla-
cental antibodies against the acetylcholine receptor2 or
mutations in genes encoding components of the neuro-
muscular endplate,7 connatal myopathies,3 and myotonic
dystrophy.8 Inheritance of AMC can be autosomal domi-
nant3 or recessive,1 but rare X-linked cases have been
described as well.9–12
Intellectual disability (ID) is a complex disorder that af-
fects 1%–3% of the general population. It is characterized
by significant limitations of intellectual functioning, adap-
tive behavior, or daily living skills with an onset before 18
years of age. Over the past decade, many ID-associated
genes have been identified by chromosome breakpoint
mapping, candidate-gene approaches, and whole-genome
array-based copy-number analysis, the latter of which al-
lows the detection of small deletions and duplications.
More recently, massively parallel sequencing has led to
the identification of many new genetic defects in familial
and simplex cases, further emphasizing the vast genetic
heterogeneity of ID.13–15 Similarly, X-linked ID (XLID),
which arises from mutations in genes on the X chromo-
some and accounts for about 10%–12% of the ID seen in
males,16 is a genetically heterogeneous disorder for which
more than 92 associated genes have been described.
Despite the large number of known mutations in genes
implicated in XLID, many families assumed to be affected
by XLID on the basis of linkage studies or pedigree struc-
ture still do not have a molecular diagnosis.
Our aim was to identify pathogenic mutations in fam-
ilies and simplex cases with the combination of AMC
plus XLID and to functionally validate the pathogenic na-
ture of the identified DNA variation in model systems. We
identified disease-causing mutations in the zinc-finger
gene ZC4H2 in five families and three unrelated simplex
cases (of both sexes) with this phenotype. In mouse pri-
mary neurons, ZC4H2 localized to the postsynaptic
compartment of excitatory synapses, and the DNA varia-
tion identified in the affected individuals influenced den-
dritic spine density. In zebrafish, zc4h2 knockdown caused
abnormal swimming and impaired a-motoneuron devel-
opment, which could not be rescued by altered proteins
containing the pathogenic substitutions.Subjects and Methods
Subjects
Individuals were recruited through neuropediatric and clinical ge-
netics outpatient clinics and the EUROMRX consortium and its
associated groups. The clinical characteristics of the persons, in
whomwe later discoveredmutations in ZC4H2, are listed in Tables
1 and 2 and Tables S1A and S1B, available online. This study was
approved by the local institutional review boards. Written
informed consent was obtained from all participants and their
legal guardians according to the Declaration of Helsinki. Informa-682 The American Journal of Human Genetics 92, 681–695, May 2, 2tion about deceased individuals was obtained through relatives
and from hospital records.
Genetic Studies
For next-generation sequencing and genetic analysis, DNAwas ex-
tracted from peripheral-blood samples or formalin-fixed tissues.
For family 1, the mutation was identified in the index male (IV-3
in Figure 1A) by the sequencing of all exons on the X chromosome
similarly to the previously described method.18 Family 2 was hap-
lotyped with 21 microsatellite markers (5–10 cM distance) with
GeneHunter,19 which revealed a 37 cM interval flanked by
DXS6810 and DXS6797 (Figure S1). A BED file with all coding
exons plus 100 bp flanking sequences of this region was generated
with GeneDistiller software20 and used for custom production of a
NimbleGen Sequence Capture Array (4.97 Mb). Fifteen micro-
grams of genomic DNA from individual V-1 (Figures 1B and S1)
and his mother (IV-6) were fragmented, captured, and sequenced
on the Genome Sequencer FLX System (Roche). Eighty-five
percent of 1.54 million reads (4215 52 bp) were aligned (average
coverage 653) and called for variants with GeneiousPro v.5.6.5
(Biomatters). Variants were then evaluated with MutationTaster
software.21 For family 3 (Figure 1C), we analyzed all coding exons
of ZC4H2with primer pairs listed in Table S2 by traditional Sanger
sequencing.
For five individuals of family 4 (I-1, I-2, II-1,II-2, and II-5 in
Figure 1D), whole-exome sequencing (WES) was performed with
Illumina TrueSeq WES protocols. The enriched DNA (350–
400 bp products) was sequenced on the Illumina HiSeq2000 plat-
form (Axeq Technologies), which returned on average 48.3 Mb of
100 bp paired-end reads per individual. These reads were quality
trimmed with the FASTX toolkit and aligned to UCSC Genome
Browser hg19 with the Burrows-Wheeler Aligner with default pa-
rameters, except for -d 5 and -l 35. SAMtools was used for gener-
ating BAM files. Sequence variants were realigned, recalibrated,
and reported with the Genome Analysis Toolkit and categorized
with Annovar. We applied different inheritance models for this
family: autosomal recessive (homozygous or compound heterozy-
gous), X-linked, and de novo (postulated germline mosaicism was
applied for one of the parents).
For family 5, all X-chromosome-specific exons were enriched
from genomic DNA of the index male (IV-1 in Figure 1D) with
droplet-based multiplex PCR similarly to the previously described
method,22 and DNAs were sequenced on the Illumina HiSeq2000
platform (ATLAS).
For segregation analysis of the ZC4H2 mutations identified in
this study, we used gene-specific primers flanking the mutations
and determined genotypes for all available family members by
Sanger sequencing of PCR products. The c.593G>A (RefSeq
accession number NM_018684) (p.Arg198Gln) mutation was
further verified by restriction-fragment-length-polymorphism
analysis and excluded in 100 alleles of healthy control subjects
from the same ethnic background: the 290 bp PCR product gener-
ated with the oligonucleotide primers 50-CTGAACTGGGTTA
TGTCCTTCC-30 (forward) and 50-CTTCCGTTTCGGCTTTTTG-30
(reverse) was cleaved by HpaII into 263 þ 27 bp in the presence
of the mutation and 218 þ 45 þ 27 bp in the absence of the mu-
tation (data not shown).
We performed X-inversion breakpoint mapping by fluores-
cence in situ hybridization (FISH) on metaphase chromosomes
of the affected boy according to standard protocols by
using bacterial artificial clones (BACs) selected from the regions
of interest (Table S3). For expression analysis in fibroblasts, we013
Table 1. Overview of Frequent Clinical Symptoms Present in Hemizygous Males
Characteristics
and Symptoms HPO ID Family 1 Family 2 Family 3 Family 4 Family 5
Simplex
Case 1
Total (per
Genotype)
Mutation NA c.187G>C
(p.Val63Leu)
c.593G>A
(p.Arg198Gln)
c.601C>T
(p.Pro201Ser)
c.637C>T
(p.Arg213Trp)
c.637C>T
(p.Arg213Trp)
de novo
X inversion
NA
Origin NA Germany Germany Netherlands Australia France Germany NA
Age at last
assessment
NA 27–74 years
(mean ¼ 56 years)
0.5–8.0 years 1.4–13.0 weeks 7.5–13.5 years 8.0–28.2 years 3.8 years NA
Age at death NA no disease-
related deaths
0.5–8.0 years 1.4–13.0 weeks no disease-
related deaths
no disease-
related deaths
no disease-
related deaths
NA
Number of affected
individuals
NA 6 5 5 2 2 1 5 genotypes
Growth
Dwarfism HPO:1516 – 2 1 – 1 1 4/5
Head and Neck
Long (flat) philtrum HPO:299 1 2 5 – – 1 4/5
Oral motor
dysfunction
HPO:5216 – 1 – – 2 1 3/5
Low-set ears HPO:369 – 2 – – 1 1 3/5
Ptosis HPO:1488 6 3 1 – 1 1 5/5
Upturned nares HPO:463 – 2 5 – – 1 3/5
Broad alveolar ridges HPO:187 – – 5 – 2 1 3/5
High-arched palate HPO:218 – 2 5 – 2 1 4/5
Carp-shaped mouth HPO:10806 1 2 5 – 2 1 5/5
Drooling HPO:2307 – 3 – 2 2 1 3/5
Short neck (with
limited rotation)
HPO:470 – 2 1 – 1 1 4/5
Respiratory
Neonatal respiratory
distress
HPO:2643 – 3 5 – – 1 3/5
Chest
Humeroscapular
mobility restriction
HPO:6467 – 2 1 – – 1 3/5
Narrow shoulders
or thorax
HPO:6664 1 3 – – 1 1 4/5
Abdomen
Poor feeding HPO:2022 – 4 – – 1 1 3/5
Skeletal
Kyphosis, lordosis,
or scoliosis
HPO:2751 1 3 1 – – 1 4/5
Congenital hip
dislocations or hip
flexion contractures
HPO:1374 – 4 2 – – 1 3/5
Short limbs HPO:9826 – – 2 – 1 1 3/5
Flexion contractures
of elbows or knees
HPO:2987,
2978
– 3 2 – 1 1 4/5
Proximally placed
thumbs
HPO:9623 – 2 1 – – 1 3/5
Camptodactyly HPO:1215 – 5 2 – – 1 3/5
(Continued on next page)
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Table 1. Continued
Characteristics
and Symptoms HPO ID Family 1 Family 2 Family 3 Family 4 Family 5
Simplex
Case 1
Total (per
Genotype)
Ulnar deviation
of the finger
HPO:9465 – 3 1 – – 1 3/5
Proximally placed
toes
HPO:1780 – 4 1 – – 1 3/5
Equinovarus feet
or contracture of
Achilles tendon
HPO:8110,
1771
6 5 2 2 – 1 5/5
Skin, Nails, and Hair
High anterior hairline HPO:294 – 2 5 – – 1 3/5
Muscle and Soft Tissue
Distal muscle
weakness
HPO:2460 6 2 – – 2 1 4/5
Edema or fat pads
(hands and/or feet)
HPO:7514 – 3 1 – – 1 3/5
Neurologic
Retardation of
motor development
HPO:1263 6 5 1 2 2 1 5/5
Intellectual disability HPO:1249 6 5 1 2 2 1 5/5
Spasticity HPO:1257 – 5 – 2 1 1 3/5
Seizures HPO:1250 – 4 1 1 2 1 4/5
Delayed myelination
on MRI
HPO:2188 – 2 1 – – 1 3/5
Diffuse cerebral
atrophy on MRI
HPO:2283 – 3 – – 1 1 3/5
This table shows the clinical symptoms seen in >50% of the five different genotypes of all affected males from families 1–5 and of simplex case 1. The entire set of
symptoms is listed in Table S1A. None of the investigated affected males showed abnormalities in motor (n ¼ 4) or sensory (n ¼ 3) peripheral nerve conduction
studies or any histological signs of amyopathy (n¼ 7). All symptoms are listed according to the nomenclature and the systematics of the OMIM ‘‘Clinical Synopsis’’
and are mapped to the Human Phenotype Ontology.17 The phenotypes of families 1 and 3 have been published.9,10 Abbreviations are as follows: HPO, Human
Phenotype Ontology; NA, not applicable; and –, symptom absent or unknown.isolated total RNA and performed RT-PCR with two different
sets of ZC4H2 primer pairs and one HPRT primer pair
(Table S2), which served as a control for cDNA integrity.
ZC4H2-specific bands were excised from agarose gels, extracted
(QIAGEN), and Sanger sequenced with the same primers as for
the amplification.
For simplex case 1, array comparative genomic hybridization
(aCGH)was performedwith the NimbleGenCGX-6 format (which
includes 135K oligonucleotide probes) according to the manu-
facturer’s protocol, and the scanned data were processed with
Genoglyphix software (Signature Genomics). For simplex cases 2
and 3, aCGH was performed with a 105K feature (case 2) or a
135K feature (case 3) whole-genome microarray (SignatureChip
Oligo Solution version 1.0 or 2.0, custom-designed by Signature
Genomic Laboratories and manufactured by Agilent Technologies
or Roche NimbleGen) as previously described.23,24
Generation of Human Wild-Type and Altered ZC4H2
Constructs for Overexpression Studies
For transient expression, full-length open reading frames of
human wild-type and altered ZC4H2 constructs from family 1
were amplified with primer sets (1) ZC4H2-EGFP-N2-EcoRI-forw
and ZC4H2-EGFP-N2-SalI-rev and (2) ZC4H2-EGFP-C2-EcoRI-684 The American Journal of Human Genetics 92, 681–695, May 2, 2forw and ZC4H2-EGFP-C2-SalI-rev (Table S2). PCR products
were double digested with EcoRI and SalI (New England Biolabs),
and the fragments were ligated into pEGFP-C2 and pEGFP-N2
(Clontech). The clones with c.637C>T (p.Arg213Trp), c.593G>A
(p.Arg198Gln), and c.601C>T (p.Pro201Ser) mutations were
generated from the wild-type constructs by site-directed muta-
genesis with the Quick Change II Site-Directed Mutagenesis Kit
(Stratagene). Myc-tagged ZC4H2 constructs were generated from
the pEGFP-C2 clones after double digestion with EcoRI and SalI
and ligation into the pCMVTag3B vector (Stratagene). Correctness
of all sequences was determined by Sanger sequencing.
Immunofluorescence Studies of Wild-Type and
Altered ZC4H2 in Cell Lines and Primary Neurons
Neuro2A cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (FBS) in the
presence of antibiotics. Hippocampi or cortices were dissected
from embryonic day (E) 17.5 C57BL/6J mouse embryos, dispersed
in cold PBS, and triturated with papain (10 U/ml) (Worthington)
for 22 min at 37C. Cells were resuspended in DMEM/Ham’s F-12
with 10% FBS and centrifuged at 400 3 g (for 3 min), and the
pellet was resuspended in primary neuron basal medium, neuro-
nal survival factor, and 0.5 mM glutamine (Lonza). Dissociated013
Table 2. Overview of Frequent Clinical Symptoms Present in Heterozygous Females
Characteristics
and Symptoms HPO ID Family 2 Family 3 Family 4 Family 5 Simplex Case 2 Simplex Case 3
Total (per
Genotype)
Mutation NA c.593G>A
(p.Arg198Gln)
c.601C>T
(p.Pro201Ser)
c.637C>T
(p.Arg213Trp)
c.637C>T
(p.Arg213Trp)
deletion of chrX:
63,666,909–64,
493,512
deletion of chrX:
64,049,596–64,
370,757
NA
Origin NA Germany Netherlands Australia France United States Spain NA
Age at last
assessment
NA – – – – 9 years 13 years NA
Number of affected
individuals
NA 1 7 1 2 1 1 5 genotypes
Genitourinary
Urine incontinence HPO:20 – 1 – – 1 1 3/5
Skeletal
Camptodactyly HPO:1215 – 5 – – 1 1 3/5
Equinovarus foot
deformity or
contracture of
Achilles tendon
HPO:8110,
1771
1 3 – – 1 1 4/5
Muscle and Soft Tissue
Distal muscle
weakness
HPO:2460 – 3 – – 1 1 3/5
Neurologic
Intellectual disability HPO:1249 – 3 1 2 1 1 4/5
Dysarthria and/or
deficit in expressive
language
HPO:1260 – 1 – – 1 1 3/5
This table shows the clinical symptoms seen in >50% of the five different genotypes of all affected females from families 2–5 and simplex cases 2 and 3. The entire
set of symptoms is listed in Table S1B. All symptoms are listed according to the nomenclature and the systematics of the OMIM ‘‘Clinical Synopsis’’ and are mapped
to the Human Phenotype Ontology.17 The phenotype of family 3 has been published.10 Abbreviations are as follows: HPO, Human Phenotype Ontology; NA,
not applicable; and –, symptom absent or unknown.cells were plated onto poly-D-lysine (SIGMA)- and laminin
(Invitrogen)-coated substrates at a density of 400 cells/mm2. For
immunofluorescence studies, human embryonic kidney (HEK)
293T and Neuro2A cells were fixed with 4% PFA 24 hr after
transfection, permeabilized in 0.2% Triton X-100, and washed at
room temperature (RT). Cells were incubated with 0.5 mg DAPI/
ml and mounted with Fluoromount (SouthernBiotech). Trans-
fected mouse hippocampal neurons were fixed with 4% PFA for
20 min and permeabilized with PBS, 3% BSA, and 0.2% Triton
X-100 for 1 hr at RT.
Per well, 5 3 104 HEK293T cells or 8 3 104 Neuro2A cells were
transfected with 1 mg plasmid DNA and 1 ml Lipofectamine 2000
(Invitrogen). Images were acquired with a confocal laser-scanning
microscope (Zeiss LSM 700) with a 633 objective and were
analyzed with the ZEISS LSM Image Browser. Mouse hippocampal
neurons were transfected at 14 days in vitro (DIV) with the use
of the Magnetofectamine transfection kit (OZ Biosciences).
Microscopy was carried out 24–48 hr after transfection. Cells
were incubated with primary antibodies mouse anti-PSD95-mAb
(1:100; ThermoFisher), goat anti-GAD65-67 (1:50; SCBT), goat
anti-VGLUT1 (1:50; SCBT), and rabbit anti-Gephyrin (1:1,000;
Abcam) diluted in blocking solution (PBS, 3% BSA, and 0.2%
Triton X-100) and with a secondary antibody (FluoProbes FP-594
donkey anti-mouse, anti rabbit, or anti-goat antibody [1:300;
Interchim]) for 45 min. Sequential acquisitions were made, andThe Amhigh-resolution z stack images of neurons were taken with the
633 objective of a confocal FluoView 500 microscope (Olympus)
with optical section separation (z interval) of 0.5 mm andmaximal
projections. The extent of colocalization was measured with
the ‘‘colocalization’’ module of the 64-bit version of Imaris 5.0.2
(Bitplane AG).25
Colocalization of ZC4H2-GFP with presynaptic and postsyn-
aptic markers was statistically analyzed with Prism Software and
the Mann-Whitney U test. The number of dendritic spines was
statistically analyzed with a one-way ANOVA (posthoc Newman-
Kewls).
Immunoblot Analysis
A total of 5 3 105 HEK293T cells were grown in 75 cm2 flasks,
and 8 mg of plasmid DNA was transfected with the use of Lipo-
fectamine2000 (Invitrogen) according to the manufacturer’s
recommendations. Twenty-four hours after transfection, cells
were lysed in lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM
NaCl, 2 mMMgCl2, 0.1% NP40, and protease inhibitors [Roche]),
sonicated, and centrifuged for 15 min at 13,000 rpm at 4C.
Immunoblots were incubated with the following primary and
secondary antibodies: goat polyclonal anti-GFP-HRP (1:10,000;
Abcam), rabbit polyclonal anti-actin (1:10,000; Sigma), peroxi-
dase-conjugated anti-mouse-HRP (1:3,000; Dianova), and anti-
rabbit-HRP (1:5,000; Amersham).erican Journal of Human Genetics 92, 681–695, May 2, 2013 685
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Figure 1. Overview of Genetic Results in Individuals with ZC4H2 Mutations Discovered by Massively Parallel Sequencing, Chromo-
some Breakpoint Mapping, and aCGH
(A–D) Pedigrees of families 1–5, affected by ZC4H2missense mutations. Asterisks indicate that a mutation is present. Filled-in symbols
represent affected individuals, and symbols with slashes represent deceased individuals. The following abbreviation is used: WT,
wild-type.
(A) Pedigree of family 1, affected by WWS.9 The c.178G>C (RefSeq NM_018684.3) mutation was verified by Sanger sequencing to
segregate with the disease phenotype in the family.
(B) Family 2 is affected by an early lethal AMC subtype that segregates with the c.593G>A mutation.
(C) Family 3, previously published by Hennekam et al.,10 is affected by an early lethal form of AMC due to a ZC4H2 c.601C>T missense
mutation.
(D) Families 4 and 5 are affected by a c.637C>T missense mutation.
(E) Multiple-sequence alignment of ZC4H2 domains in five species and conservation of the substituted amino acids (colored and boxed).
Amino acid residues of the ZC4H2 zinc-finger domain in the C terminus are underlined.
(F) Schematic view of the X chromosome with the 96 kb breakpoint region in Xq11.2 determined by fluorescence in situ hybridization
(FISH) and the position and exon-intron structure of ZC4H2. For simplicity, we show only two out of five alternative transcripts. Arrows
above the exons indicate the direction of transcription. Breakpoint-spanning clones in the boy with the X inversion are presented as
green horizontal lines.
(G) FISH results for BAC RP13-524D22 from Xq11.2 with split signals in Xq11.2 and Xq28 (arrows) indicate that this clone spans the
breakpoint.
(H) RT-PCR expression results of ZC4H2 (upper) andHPRT (lower) in the fibroblasts of the boy with the X inversion (P) and of the control
(C). For ZC4H2 RT-PCR amplifications, we used two different primer pairs (indicated by 1 and 2 below the agarose-gel picture) and found
(legend continued on next page)
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Zc4h2 Expression Analysis in Mouse Brain Tissues and
Primary Cortical Cultures
All mouse experiments were performed according to protocols
approved by the Committee on Use and Care of Animals at the
University Franc¸ois-Rabelais (Tours, France) and by the Institut
National de la Sante´ et de la Recherche Me´dicale (Paris, France).
TissueScan qPCR Arrays (OriGene) were used for screening for
Zc4h2 expression in 48 samples covering five stages of embryonic,
postnatal, and adult brain tissues with the use of Soadvance Syber
(BioRad) gene expression assays. The prestandardized cDNAs were
amplified by PCR using a primer set specific to Zc4h2 (Table S2).
RNAwas extracted from primary cortical neurons after 5, 10, 14,
and 21 days in culture. cDNAwas synthesized with the QuantiTect
RT kit (QIAGEN). Quantitative PCR (qPCR) was done with the use
of 50 ng cDNA as a template with SsoFast Eva Green (BioRad)
reagent. The same specific primer set was used for expression
assays in mouse tissues. The assays were performed in duplicate
on LightCycler480 (Roche). Quantification was carried out by
the 2-DDCp method. The normalized ratio was obtained for each
target gene with the use of LC480 software, qPCR efficiencies
were considered, and reference genes Cyc1, Sdha, and Gapdh
were used for normalization.
Zebrafish Whole-Mount In Situ Hybridization
Zebrafish were bred and maintained according to approved guide-
lines prescribed by the Committee on Use and Care of Animals
at the National Institute of Genetics (Japan). For in situ hybridi-
zation, embryos at 24 and 48 hr postfertilization (hpf) were fixed
overnight with 4% PFA in PBS. Embryos were then dehydrated
with ascending concentrations of methanol and stored at 20C
overnight before rehydration with descending concentrations of
methanol and treatment with proteinase K to increase perme-
ability. Sense and antisense cRNA probes were generated with
the DIG RNA labeling kit (Roche) according to the manufacturer’s
instructions. Probe hybridization was performed overnight at
65C and was detected with a DIG antibody conjugated to alkaline
phosphatase (Roche), resulting in color development when the
substrates nitro blue tetrazolium chloride and 5-bromo-4-chloro-
indolyl phosphate were added. In situ hybridization using a sense
probe did not detect any significant signal.
Knockdown and Rescue Experiments in Zebrafish
Zebrafish zc4h2 (RefSeq NM_199642) was cloned into a pCR4-
TOPO vector (Invitrogen) and used for cRNA synthesis. Antisense
morpholino oligonucleotides (MOs) were designed against the
translation initiation codon (MO1) and the splice donor site
between exon 2 and intron 2 (MO2) of zebrafish zc4h2. Zebrafish
embryos were injected with 5 ng of MOs at 1- to 2-cell stages
and studied as previously published.26 At these dosages, control
MOs produced no discernible phenotype change. For rescue
experiments, zebrafish zc4h2 and mouse Zc4h2 (RefSeq
NM_001003916) were cloned into the pCS2þ expression vector
and missense mutations were introduced into the mouse clone
by site-directed mutagenesis. All primer sequences are presentedwith both sets that ZC4H2 transcripts were lacking in the affected in
one band in lane 5) were present in a male control. HPRT RT-PCR serv
marker; þ, addition of reverse transcriptase enzyme (RT); and –, neg
(I) Schematic view of the deletions identified by aCGH in two affect
respective deletion in each of the affected individuals. Both deletion
gene.
The Amin Table S2. Capped RNA was synthesized with the mMESSAGE
mMACHINE SP6 kit (Life Technologies) according to themanufac-
turer’s protocol. Capped RNA (100 pg) was coinjected with MO2
(4 ng) into zebrafish embryos at 1- to 2-cell stages. At 2 days post-
fertilization (dpf), normal zebrafish embryos swam away rapidly
(>2 cm/s) upon tactile stimulation. The number of embryos that
exhibited slow swimming (<2 cm/s) after touch was counted.
For labeling of motoneurons and neuromuscular junctions
(NMJs) in zebrafish, embryos were fixed in 4% PFA, washed in
PBS, and labeled. Motor axon projections were labeled with a
znp-1 antibody (antisynaptotagmin 2, 1:100, DSHB) and an
AlexaFluor488-conjugated anti-mouse IgG secondary antibody
(Life Technologies). NMJs were labeled with a-bungarotoxin
conjugated with AlexaFluor594 (Life Technologies).Results
Clinical Delineation of a Syndrome with AMC plus ID
We initially studied two large families (families 1 and 2)
who are compatible with X-linked recessive inheritance
and in whom multiple malformations are associated
with ID. Although contractures of the feet were one of
the main clinical symptoms in family 1, affected by
Wieacker-Wolff syndrome (WWS [MIM 314580]),9 the
children of family 2 presented with neonatal respiratory
distress, AMC, muscle weakness, and ptosis. These features
suggested dysfunction of neuromuscular transmission in
utero. As development progressed, it became clear that
the affected boys of family 2 were also severely intellectu-
ally disabled. Correspondingly, the affected males from
family 1 also had signs of a developmental defect of neuro-
muscular transmission, albeit in a much more attenuated
form, as seen by congenital equinovarus foot deformity
and ptosis. Central symptoms—besides ID—that were
seen in the majority of individuals were spasticity due to
involvement of upper motor neurons and seizures as a
manifestation of disturbed formation of the cerebral
network. Histological investigation did not provide evi-
dence of a demyelinating or axonal neuropathy or a myop-
athy (see below). Phenotypic analysis of heterozygous
females revealed mild ID, and in several individuals, addi-
tionalminor dysmorphic signs, such as camptodactyly and
equinovarus feet, were present. The phenotype of family 3
had been published previously.10 As a result of our findings
and the presence of multiple contractures, respiratory
distress, and severe ID in the family, we contacted the
authors and enrolled this family into our study. Family 4
had been included in a larger study aimed at identifying
novel genes for cerebral palsy (CP). Because the inheritance
pattern of CP in the family was not unequivocally X
linked, five individuals (affected and unaffected) weredividual but that the expected products (three bands in lane 4 and
ed as a control for cDNA integrity. Abbreviations are as follows: M,
ative control.
ed girls (simplex cases 2 and 3). Blue horizontal bars indicate the
s include ZC4H2 (indicated by the red bar), but no other known
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Figure 2. Clinical Photographs and Cranial MRIs of Two Affected Boys from Family 2 and a Simplex Case
(A) Male child IV-8 (family 2) shows facial weakness, low-set and posteriorly rotated ears, and strabismus. He has bilateral camptodactyly
and equinovarus feet with small, proximally placed toes.
(B) Male child V-1 (family 2) shows prominent facial weakness, a flat philtrum, strabismus, upturned nares, a carp-shapedmouth, narrow
shoulders, and muscular hypotonia. The contracted fingers cannot be opened passively and show characteristic fat pads over the
extensor surfaces.
(C) Axial and parasagittal cranial MRIs (cMRIs) of individual V-1 (family 2) at the age of 22 months (left column) and an age-matched
control (right column). In the affected child, frontal brain atrophy (open arrowheads) and hypoplasia of the corpus callosum (closed
arrowheads) are depicted in the sagittal T2-weighted image. The fluid-attenuated-inversion-recovery image (middle panel) shows abnor-
mality of the periventricular white matter mainly in the occipital region (closed arrowheads).
(D) Female simplex case 3 shows narrow shoulders, proximally placed thumbs, camptodactyly, radial and ulnar deviation of the fingers,
and mild equinovarus feet.analyzed by WES. The heterozygous girl from this family
(II-7 in Figure 1D) was assessed at the age of 3.75 years.
She had a significant deficit of language development
(especially of perceptive language) and of personal and so-
cial skills. Her fine and gross motor abilities, however, were
appropriate for her age. She had neither CP nor joint con-
tractures. The family 5 index individual, who presented
with ID and additional clinical symptoms similar to those
of the affectedmales of families 2 and 3, had been included
in the EUROMRX cohort and thus has been sequenced for
all X-chromosome-specific exons. For more clinical details
on all affected individuals from families 1–5 and simplex
cases 1–3, see Tables 1, 2, S1A, and S1B. We can single
out retardation of motor development, ID, and equinova-
rus feet as the minimum common phenotypic denomina-
tors of WWS for all different mutations described in this
article. The syndrome thus represents a clinically distinct
and phenotypically broad neurodevelopmental disorder
of the central and peripheral nervous systems.
Next-Generation Sequencing Identifies Missense
Mutations in ZC4H2
In an effort to find pathogenic mutations in families
affected by syndromic and nonsyndromic forms of XLID,688 The American Journal of Human Genetics 92, 681–695, May 2, 2we identified the disease-causing mutation in a family
afflicted with WWS27,28 by sequencing all X chromosome
exons. After all identified variants were filtered against
publicly available data, the only one that remained was a
missense mutation in exon 3b (c.187G>C [p.Val63Leu])
of the zinc-finger gene ZC4H2 (RefSeq NM_018684.3).
This mutation cosegregated with the disease in the
WWS-affected family (family 1 in Figure 1A). In family 2,
linkage analysis localized the responsible locus between
DXS6810 and DXS6797, and deep sequencing of the link-
age interval and subsequent segregation analysis indicated
a cosegregating mutation in exon 6 of ZC4H2 (c.593G>A
[p.Arg198Gln]) (Figure 1B). Clinical photographs and
MRIs of two affected boys are presented in Figures 2A–
2C. For family 3,10 we used gene-specific primers to search
all ZC4H2 exons and exon-intron boundaries by PCR
and Sanger sequencing for a mutation in the mother
(III-14 in Figure 1C) of one affected male. This analysis
revealed in ZC4H2 exon 6 another transition (c.601C>T
[p.Pro201Ser]), which was also present in the heterozygous
form in her two sisters (III-6 and III-7 in Figure 1C). For
family 4, we performed WES on five family members (I-1,
I-2, II-1, II-2, and II-5 in Figure 1D) because the inheritance
pattern was inconclusive. In seven genes, we identified013
unique sequence variants, which were subsequently vali-
dated. The three X chromosome variants—c.637C>T
(p.Arg213Trp) in ZC4H2 (Figure 1C), c.20T>A (RefSeq
NM_152423.4) (p.Leu7Gln) in MUM1L1, and c.3140G>A
(RefSeq NM_032968.3) (p.Gly1047Glu) in PCDH11X
(MIM 300246) (data not shown)—were predicted to result
in amino acid changes. All three variants segregated in
the extended family (whole-exome-sequenced individuals,
as well as the remaining sibling) according to postulated
X chromosome inheritance (data not shown), and as
such, we could not distinguish which one was causative.
However, during data analysis, the latter two variants (in
MUM1L1 and PCDH11X) appeared as SNPs in the latest
release of dbSNP135 and were thus considered to be rare,
noncausative variants. Of the identified autosomal vari-
ants, the potentially compound-heterozygous change in
SLC11A2 (MIM 600523) was not confirmed by Sanger
sequencing and the two MYH14 (MIM 608568) changes
were both on the same allele (i.e., not compound heterozy-
gous). These MYH14 variants did not segregate, given that
the healthy mother and her healthy daughter had them as
well. The de novo heterozygous variants in FLNB (MIM
603381) and PLAC4 (MIM 613770) were not confirmed
by Sanger sequencing (data not shown).
The same ZC4H2 mutation as was found in family 4
(c.637C>T [p.Arg213Trp]) was identified in the affected
male from family 5 (IV-1 in Figure 1D) by massively
parallel sequencing of all X-chromosome-specific exons
with the use of a PCR-based enrichment strategy. The
mutation was also present in his mother (III-2), his
affected uncle (III-6), and two other female relatives
(II-2 and III-4) (Figure 1D). Representative sequence chro-
matograms of all mutations from families 1–5 are shown
in Figure S2.
All ZC4H2 amino acid positions affected by identified
mutations are highly conserved (Figures 1E and S3). The
new amino acids are predicted to be damaging to ZC4H2
function by PolyPhen-2 and MutationTaster.17 Such
changes were not detected in publicly available databases,
including the 1000 Genomes Project database, dbSNP135,
and the National Heart, Lung, and Blood Institute (NHLBI)
Exome Sequencing Project Exome Variant Server. More-
over, when tested in 100 ethnic controls (males), the
c.637C>T (p.Arg213Trp) mutation was not detected.
None of the changes were present among >450 X chromo-
some exomes from males with XLID (data not shown).
Importantly, no other variants (X linked or autosomal)
identified and segregating in these families were predicted
to be deleterious.
An X Chromosome Inversion Abolishes ZC4H2
Expression in a Severely Affected Boy
We also examined a severely affected boy (simplex case 1 in
Tables 1 and S1A) with a phenotype similar to that of the
affected boys of families 2 and 3; he was found to have a
paracentric de novo inversion on the X chromosome
with breakpoints at Xq11.2 (location of ZC4H2) andThe AmXq28. Using serial FISH, we mapped both breakpoints to
intervals of <150 kb (Figures 1F and 1G and Table S3).
Whereas the breakpoint region at Xq28 did not contain
any known gene (Figure S4), the mapped region at
Xq11.2 contained ZC4H2, which led us to speculate that
the rearrangement might interfere with the normal ex-
pression of this gene. We thus performed RT-PCR experi-
ments with two different primer sets on RNA isolated
from cultured skin fibroblasts of the affected male and a
control. The results showed that unlike in the normal
control, no ZC4H2 transcripts were detectable in mRNA
from the affected male (Figure 1H), indicating that the
rearrangement abolished ZC4H2 expression.
aCGH Identifies Mildly Affected Females with Single
Allelic Deletions of the ZC4H2 Locus, and ZC4H2
Is Subject to X Inactivation
Using whole-genome microarray analysis, we also identi-
fied small heterozygous deletions at Xq11.2 in two mildly
affected girls (simplex cases 2 and 3 in Tables 2 and S1B and
Figures 1I and S5). In simplex case 2, the deletion removed
about 826 Kb of the X chromosome genomic DNA (chrX:
63,666,909–64,493,512 [UCSC Genome Browser hg19])
and was absent in her mother. In simplex case 3, the dele-
tion encompassed about 321 Kb (chrX: 64,049,596–
64,370,757 [UCSC Genome Browser hg19]). Clinical pho-
tographs are presented in Figure 2D. Additional parental
DNA was unavailable for further testing. Both deletions
included ZC4H2, but not any other adjacent gene, and
allowed us to conclude that heterozygous deletions of
ZC4H2 can result in a clinical phenotype.
To investigate whether ZC4H2 might be subject to X
inactivation, we determined its expression level in blood
lymphocytes from healthy males and females by microar-
ray analysis. Its relative expression level compared to those
of other genes known to be expressed from only one or
from both X chromosomes suggested that ZC4H2 is sub-
ject to X inactivation in females (Figure S6). We next deter-
mined the X inactivation status of healthy and affected
females who carried a heterozygous missense mutation
or deletion of ZC4H2. We observed preferential inactiva-
tion of the mutated X chromosome in all females tested,
except for the affected girl of family 4 and her unaffected
mother (data not shown). An overview of all genetic results
is provided in Table S4.
ZC4H2 Is Expressed in the Central and Peripheral
Nervous Systems of Humans, Mice, and Zebrafish
The functional role of ZC4H2 is not well characterized. We
therefore first investigated its expression pattern and
found it to be transcribed in human fetal brain and other
tissues (Figure S7). In mouse and zebrafish embryos,
Zc4h2 and zc4h2, respectively, are strongly expressed
throughout the brain and in the spinal cord (Figure 5A
and Mouse Genome Informatics [see Web Resources]).
These results prompted us to investigate the in vivo ex-
pression pattern of Zc4h2 during neurodevelopment inerican Journal of Human Genetics 92, 681–695, May 2, 2013 689
Figure 3. Mouse Zc4h2 Is Expressed
in Various Brain Tissues and the Spinal
Cord, and its Expression Is Reduced
Postnatally
Zc4h2 mRNA expression was assessed by
quantitative RT-PCR using SYBR Green I
protocol and arrays containing cDNA
from 48 mouse samples. The tissues
represented are telencephalon, frontal
cortex, posterior cortex, entorhinal cortex,
olfactory bulb, hippocampus, striatum,
mesencephalon, midbrain, rhombenceph-
alon, pons, medulla, cerebellum, dien-
cephalon, thalamus, hypothalamus, and
spinal cord. Five developmental stages
were investigated: E13, E15, E18, postnatal
day 7 (P7), and adult week 5 (A5). Expres-
sion of Zc4h2 mRNA is shown relative to
the Gapdh reference gene.various mouse brain regions and spinal cord of different
developmental stages. Interestingly, in all brain areas,
Zc4h2 expression was highest during embryonic develop-
ment and declined postnatally, suggesting an important
role of Zc4h2 during brain development (Figure 3). A
similar dynamic gene expression was evident in cultures
of mouse primary cortical neurons: there was a significant
decline of Zc4h2 expression in more mature neurons than
in immature neurons (p < 0.05) (Figure S8).
High Levels of Altered ZC4H2 Reduce the Number
of Dendritic Spines
To gain further insight into the functional role of ZC4H2,
we studied the subcellular localization of wild-type and
altered proteins in cell lines and mouse primary neurons.
Transient transfection of tagged ZC4H2 constructs led
to the stable production of the corresponding protein
(Figure S9). Immunofluorescence analysis of altered and
wild-type ZC4H2 in Neuro2A and HEK293T cells showed
its presence in both the nucleus and the cytosol.
Compared to that of wild-type constructs, overexpres-
sion of constructs containing the missense mutations
identified in the families did not reveal any obvious
changes (Figure S10 and data not shown). Subsequent
analysis showed that human ZC4H2 was distributed
in mouse primary hippocampal neurons similarly to in
Neuro2A and HEK293T cells (Figure 4A). A more detailed
analysis showed that both wild-type and altered ZC4H2
localized at excitatory postsynaptic sites, as verified by
a predominant colocalization with PSD95, but not in
inhibitory synapses (Figures 4B, 4C, and S11). In subse-
quent follow-up studies, using altered constructs con-
taining the missense mutations, we found that compared
to wild-type ZC4H2 and GFP alone, the p.Val63Leu,
p.Arg198Gln, and p.Pro201Ser substitutions caused
a significant decrease in synapse number and density.
Remarkably, the p.Arg198Gln and p.Pro201Ser substitu-
tions, which caused a more severe clinical phenotype in
the affected individuals, were most deleterious (Figures
4D and 4E). We obtained similar results with Myc-tagged690 The American Journal of Human Genetics 92, 681–695, May 2, 2constructs, which we used to exclude any potential effect
of GFP on ZC4H2 (data not shown).
Knockdown of zc4h2 in Zebrafish Results in Impaired
Swimming and a Reduced Number and Disorganized
Pattern of Neuromuscular Endplates
Finally, we investigated the loss of zc4h2 function in zebra-
fish by knockdown with two different antisense MOs, one
designed against the translation initiation codon and the
other against the splice donor site between exon 2 and
intron 2 of zc4h2. This knockdown did not result in any
gross morphological abnormalities, but the morphants
showed impaired swimming capability at 2–3 dpf as a
result of compromised swimming contractions (Figure 5B
and Movies S1 and S2). This defect could be rescued with
wild-type zebrafish zc4h2 and with mouse Zc4h2 cDNA
constructs, but not with constructs carrying the missense
mutations of families 1–5 (Table S5). Because slow swim-
ming might be due to muscle weakness, we next investi-
gated the effect of zc4h2 ablation on the development of
the motoneurons, the myotome, and the NMJ. In contrast
to control embryos, zc4h2 morphants had shorter and
less branched motoneurons projecting from the spinal
cord by 27 and 48 hpf, demonstrating a slower pace of
axon growth and branching. a-bungarotoxin staining
revealed a reduced number and disorganized pattern of
neuromuscular endplates in zc4h2 morphants compared
to controls (Figure 5C).
Because muscle-fiber growth depends on the timely and
correct establishment of the NMJ,29 we measured fiber
diameters in muscle-biopsy specimens taken from five
affected boys of family 2 at different ages. Until 6 weeks of
age, the fibers were smaller and later normalized in size,
suggesting delayed innervation (Figure S12A). A disorder
of myelination was excluded by electron microscopy
(Figure S12C). The formation of the neuromuscular end-
plate is a carefully orchestrated process of axon trajectories
through growth-cone choices and targeting of the myo-
fiber, and an imbalance of muscle agonists and antagonists
results in permanent contractures and arthrogryposis.30013
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Figure 4. Recombinant ZC4H2 Localizes to Excitatory Postsynaptic Sites in Primary Hippocampal Neurons, and Altered Proteins
Cause a Significant Decrease in Dendritic Spine Number and Density
(A) Confocal image of a living mature mouse primary hippocampal neuron (DIV 16) with transiently produced ZC4H2-GFP (36 hr after
transfection) shows that the protein is present throughout the cell (three independent transfections; 15 cells; scale bar represents 50 mm).
The right-hand panel shows a higher magnification of a single neurite (scale bar represents 2 mm). The comparative analysis of neurons
transfected with the pEGFP vector used for cloning did not reveal any change in neuronal morphology, nor did we see any differences
between GFP-tagged and Myc-tagged constructs (data not shown).
(B) Confocal images of fixed primary hippocampal neurons (DIV 16) with ZC4H2-GFP (36 hr after transfection). Immunostaining with
PSD95 (excitatory postsynaptic marker) or VGLUT (excitatory presynaptic marker) antibodies revealed a postsynaptic localization of
ZC4H2-GFP in excitatory synapses (n ¼ 3 transfections; 12 cells; scale bar represents 5 mm). Arrows indicate domains of colocalization.
(C) Quantification of the mean percentage of colocalization of ZC4H2 with endogenous PSD95 and VGLUT (excitatory synapse) and
with endogenous gephyrin and GAD (inhibitory synapse) (Mann-Whitney U test; **p < 0.01). The following abbreviation is used: ns,
not significant. Error bars represent the SEM.
(D) Confocal images of dendrites and dendritic spines of mature neurons (DIV 16) transfected with pEGFP (negative control), ZC4H2-
GFP, ZC4H2 p.Arg213Trp-GFP, ZC4H2 p.Val63Leu-GFP, ZC4H2 p.Arg198Gln-GFP, or ZC4H2 p.Pro201Ser-GFP plasmids. For each neuron
that was further analyzed, we counted the number of spines in 10 mm sections: pEGFP (1 transfection; 8 cells; 47 spines), ZC4H2 (3 trans-
fections; 18 cells; 111 spines), ZC4H2 p.Arg213Trp (3 transfections; 23 cells; 151 spines), ZC4H2 p.Val63Leu (3 transfections; 7 cells;
47 spines), ZC4H2 p.Arg198Gln (3 transfections; 11 cells; 94 spines), and ZC4H2 p.Pro201Ser (3 transfections; 18 cells; 156 spines).
(E) Quantification of the mean number of dendritic spines for the transiently expressed GFP, wild-type ZC4H2, and altered ZC4H2.
Error bars represent the SEM.
The statistical comparative analysis was performedwith PRISM software and a one-way ANOVA test (posthocNewman-Kewls). *p< 0.05;
**p < 0.01; ***p < 0.001. The following abbreviation is used: ns, not significant.
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Figure 5. Zebrafish zc4h2 Is Expressed
in the Brain and Spinal Cord, and its
Knockdown Causes Compromised Swim-
ming Contractions and Abnormal a-Moto-
neuron Development
(A) Whole-mount in situ hybridization
with a zc4h2 probe at 24 hpf (upper row)
and 48 hpf (lower row). Embryos show
zc4h2 expression in the forebrain, mid-
brain, hindbrain, and spinal cord.
(B) Superimposed images of tail movement
at 48 hpf. Compared to animals injected
with control MOs, zc4h2-knockdown
zebrafish (lower) show weak swimming
contraction.
(C) At 27 and 48 hpf, outgrowth of
spinal cord motoneurons and formation
of NMJs are morphologically affected in
zc4h2 morphants, but not in controls.Discussion
We report the association between mutations in the
X-linked zinc-finger gene ZC4H2 and a disease phenotype.
Mutations in ZC4H2 were identified in intellectually
impaired individuals in four AMC-affected families and
in one CP-affected family. On the basis of in silico analysis,
ZC4H2 had previously been suggested as a candidate for
XLID.31 In several families, females with heterozygous
ZC4H2mutations were also affected, but to a lesser degree.
Furthermore, we found two ZC4H2 deletions and one rear-
rangement in two female and one male unrelated simplex
cases, respectively. These findings, along with the clinical
findings in heterozygous females from families 2–5, indi-
cate that females with ZC4H2 mutations might also be
affected. This is corroborated by a recently published fe-
male who has joint contractures32 and other symptoms692 The American Journal of Human Genetics 92, 681–695, May 2, 2013and who carries a heterozygous dele-
tion that removes ZC4H2 in addition
to other genes.
ZC4H2 amino acids, which are
affected by damaging mutations, are
highly conserved and predicted to
be functionally relevant. In families
1–5, the disease severity correlated
with the severity of the underlying
mutation. The location of the
p.Val63Leu substitution (family 1) in
a potential coiled-coil domain is pre-
dicted to alter secondary structure
and slightly destabilize the local
protein conformation.33 This substi-
tution caused a comparatively mild
phenotype in females with this
mutation. The p.Leu198Gln and
p.Pro201Ser substitutions (families 2
and 3, respectively), associated with
a severe lethal phenotype, lie within
the highly conserved zinc-fingerdomain (Figure S3) and are predicted to compromise the
domain’s function.33 The p.Arg213Trp substitution (fam-
ilies 4 and 5) is located in the protein’s highly conserved
C terminus, which cannot be assigned a known domain
function or structure. The disease severity of these individ-
uals is intermediate. Importantly, some females with the
p.Arg213Trp substitution have developmental delay but
are normal otherwise. We hypothesize that the different
affection statuses of females with a heterozygous ZC4H2
mutation might be related to varying X inactivation.
The results obtained in peripheral-blood lymphocytes
were consistent with the presence of symptoms in some
heterozygous females, but not in others. However, because
the X inactivation pattern in the nervous system can
differ from that seen in the blood, as reported for Rett
syndrome,34 investigation of blood cells might not be
suitable for predicting the phenotype.
Given the clinical phenotypes, we conclude that ZC4H2
should have a neuronal function during fetal growth. Our
expression studies in mouse brain tissues of different
developmental stages indicate that the gene has its highest
level of expression during embryogenesis and that mRNA
levels decline after birth. In primary hippocampal mouse
neurons, transiently produced ZC4H2 controls the
number of dendritic spines, and the magnitude of spine
reduction reflects the severity of the clinical phenotype.
In zebrafish, zc4h2 knockdown caused abnormal swim-
ming and impaired a-motoneuron development. The
deleterious nature of the ZC4H2 variants found in this
study is supported experimentally by failure of all missense
mutations to rescue the swimming defect of zebrafish
morphants.
Apart from in our studies, the role of ZC4H2 has only
been investigated in Caenorhabditis elegans, where a homo-
zygous deletion of zc4h2 (called vab-23) was found to be
lethal at early larval stages because of failed ventral closure.
Neuron-specific rescue of vab-23 in ventral neuroblasts
entirely rescued the phenotype. The authors hypothesized
that vab-23 might be a nuclear transcription factor with
an influence on gene expression for secreted cues that
regulate different steps of morphogenesis.35 It was subse-
quently demonstrated that vab-23 acts under the control
of the hox-gene lin-39 and binds directly to the smp-1 pro-
moter to induce smp-1 (semaphorin 1a) transcription.36
Semaphorins are a group of key signal proteins that
act through their receptor proteins (neuropilins and
plexins) and are essential for neuronal pathfinding, axon
sorting and branching, endplate formation, dendrite spec-
ification, and synaptic specificity.37 The general impor-
tance of axonal-guidance ligands in the pathophysiology
of arthrogryposis has recently been supported by the dis-
covery of mutations in endothelin-converting enzyme-
like 1 (ECEL1) (MIM 605896 and 615065). Corresponding
alterations of endopeptidase ECEL1 prevent the intramus-
cular branching of a-motoneurons and the formation of
sufficient NMJs, resulting in distal arthrogryposis without
central nervous symptoms.38,39
Dysregulation of axonal-guidance molecules (e.g., sema-
phorins or ephrins) might thus be the common denomina-
tor for the complex phenotype seen in the individuals
with symptoms that affect central neuronal circuits (ID,
seizures, gyral and white-matter abnormalities, and,
occasionally, CP) and the peripheral nervous system
(arthrogryposis and muscle weakness).
Taken together, the X-linked gene ZC4H2 plays an
important role during embryonic development of the cen-
tral and peripheral nervous systems. Although the variable
clinical manifestation of ZC4H2 mutations, ranging from
lethality in some affected males to very mild or absent
symptoms in some females who have the mutation, might
be explained in part by skewed X inactivation, other ge-
netic, environmental, or stochastic factors might also be
involved. Our results suggest the importance of including
ZC4H2 in genetic testing of individuals presenting withThe AmID plus muscle weakness and AMC (or at least equinovarus
feet).Supplemental Data
Supplemental Data include 12 figures, 5 tables, and 2 movies and
can be found with this article online at http://www.cell.com/
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